• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Frost & Sullivan: Economic Downturn Creates Ripples on the European Pharmaceuticals Water Market

Posted on: Monday, 9 February 2009, 02:30 CST

Impact on the European Pharmaceuticals Water Market, 18 February at 3:00 pm GMT.

LONDON, Feb. 9 /PRNewswire/ -- Although the impact of the economic downturn has been felt throughout all industrial sectors, many thought that its impact on Pharmaceutical industries would be insignificant. However, the uncertain economic environment is beginning to cause this industry to take a new approach. Currently, the treatment equipment suppliers will be able to sustain revenues through 2009 due to their already secured and contracted projects, but now pharmaceutical companies will hold back investments which could impact the project pipeline and result in a cyclic impact.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

On the European Pharmaceuticals Water Market Frost & Sullivan will host an online briefing to be held on 18 February, 2009 at 3:00 pm GMT.

"The economic slowdown that started in the United States of America is now spreading across the globe. The pharmaceutical companies in Europe will also be impacted by the current economic downturn and this will force them to rethink about their future investment plans which will include both new build as well as upgrade/rebuild/refurbishment plans. The pharmaceutical companies would take a wait and watch approach, the impact of this is expected to trickle down and impact the revenues for process water and wastewater equipment suppliers in 2010," states Karthikeyan Ravikumar, Research Associate for Frost & Sullivan.

The anticipated change in this industry could have a tangible impact as Europe is the world's second largest pharmaceutical market, housing some of the world's major pharmaceutical companies. High purity water is essential to the manufacturing and cleaning process of all drug manufacturing facility. The demand for high purity water in pharmaceutical industries makes it a key industrial end user for water treatment equipment suppliers.

This briefing will be focused on the impact of the current financial slowdown on the process water equipment suppliers for pharmaceutical industries. It will also cover the general process water and wastewater treatment market in the European pharmaceuticals industry, emerging technologies and their prospects, revenue forecasts by geographic regions, and technologies and the competitive structure.

The information presented will be of specific interest to any water & wastewater treatment equipment suppliers, turnkey solution providers, original equipment manufacturers (OEM's), UV system suppliers, membrane system suppliers, integrated solution providers and treatment companies planning to venture into the pharmaceutical market.

To participate, please email Chiara Carella at chiara.carella@frost.com with the following information: your full name, company name, title, telephone number, e-mail, address, city, state and country. Upon receipt of the above information, a registration link will be e-mailed to you. You may also register to receive a recorded version of the briefing at anytime by submitting the aforementioned contact details.

GIL 2009: Europe

Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London. For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth. To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Chiara Carella, Head of Corporate Communications for Frost & Sullivan in Europe, at chiara.carella@frost.com. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled. For more information you can also visit www.frost.com/giluk

About us

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

Contact: Chiara Carella Head of Corporate Communications P: 0044 (0) 207 3438314 E: chiara.carella@frost.com http://www.frost.com

SOURCE Frost & Sullivan

Source: PR Newswire

More News in this Category